Atopic dermatitis (eczema) trials in Argentina

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

  Where

  Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aires, Rosario

  Age

  6 months to 18 years

  People

  338 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT05735483 · EU 2022-501478-21-00
• Phase 2Taking people
  Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  Where

  CABA, Rosario

  Age

  18 years to 100 years

  People

  224 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06947993 · EU 2024-519081-49-00
• No phaseTaking people
  Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.

  Where

  Ciudad Autónoma de Buenos Aire

  Age

  6 months to 15 years

  People

  100 worldwide

  Run by

  NAOS Argentina S.A.

  See details and how to joinNCT05575882